PCI Pharma Services announces new Director of Clinical Supply Chain

Biopharmaceutical services provider PCI Clinical Services (PCI) has announced the appointment of Lisa Spence as Director of Clinical Supply Chain - International Region.

Based in the UK, Lisa Spence will partner with Katy Ostertag-Johnson, Director of Clinical Supply Chain, North America, to build and lead the expansion of PCI's SMART Supply Management team. The aim is to provie a harmonised global service offering for clients executing global studies in both domestic and emerging market geographies.

PCI supports commercial and investigational trial medicines destined for more than 100 countries around the world and has recently expanded operations into newly acquired locations in Dublin, Ireland; Melbourne, Australia; and San Diego, California.

PCI's SMART team directly supports clients in clinical study design and execution, facilitating smooth and efficient clinical trial supply strategies including forecasting of clinical supply demand, building drug projections, dynamic inventory management and overseeing tailored packaging, labelling and distribution models.

The team leverages expertise in factors such as assessing clinical protocol revisions and analyse enrollment rates, usage and trends to benefit clients.

In this new role at PCI, Lisa brings significant logistics, operations, regulatory and clinical supply experience - having previously held senior positions at sponsor companies including MedImmune, Pfizer, GSK, and Merck.

Brian Keesee, PCI Vice President and General Manager, Global Clinical Operations and Supply, said: "Lisa is highly talented and we are delighted to welcome her to PCI. With her considerable experience in logistics and operations for global clinical studies, she will be instrumental in providing our clients with invaluable insights and best practices for executing studies more quickly and effectively."

You may also like